Paperpal Prime Logo

American Journal of Cardiovascular Drugs : Impact Factor & More

eISSN: 1179-187XpISSN: 1175-3277

Key Metrics

CiteScore
5.9
Eigenfactor
0.001 - 0.005
H-Index
57
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in American Journal of Cardiovascular Drugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in American Journal of Cardiovascular Drugs

Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Transplant Recipients: A Systematic Review and Meta-analyses.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Transplant Recipients: A Systematic Review and Meta-analyses.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.
  • 1 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions

FAQs on American Journal of Cardiovascular Drugs